Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Norway Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20061
20071
20082
20102
20112
20121
20141
20153
20162
20171
20181
20191
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting3
Recruiting3
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Oslo University Hospital4
Bayer3
University Hospital, Akershus3
Haukeland University Hospital2
Hoffmann-La Roche2
AbbVie1
Daiichi Sankyo1
Fore Biotherapeutics1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms26
Heart Failure3
Neoplasms3
Ovarian Neoplasms2
Prostatic Neoplasms2
Urinary Bladder Neoplasms2
Biliary Tract Neoplasms1
Bone Diseases1
Bone Neoplasms1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.